HCV-associated Marginal Zone Lymphoma · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	surveillance
Linked regimen	`None`

ID	`IND-SJOGREN-MALT-LYMPHOMA-PREVENTION-OBSERVATION`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-HCV-MZL`
Sources	`SRC-NCCN-BCELL-2025`

Notes

STUB — alternative-track companion for Sjögren's / MALT prevention. Required for §15.2 C4 ≥2-tracks invariant. Two-Co-Lead signoff queued.

Used By

Red flag

RF-SJOGREN-MALT-LYMPHOMA-PREVENTION - Primary Sjögren's syndrome (chronic autoimmune exocrinopathy with characteristic anti-Ro/...